Have your own idea? Try our Stock Screener
Taiwanese (TAIEX) Healthcare Services Industry Analysis
UpdatedMay 21, 2026
DataAggregated Company Financials
Companies23
- 7D-0.8%
- 3M-10.0%
- 1Y-21.2%
- YTD-15.4%
The Healthcare Services is pretty flat in the last 7 days, but Excelsior Medical has stood out, gaining 3.4%. As for the longer term, the industry has declined 21% in the last year. As for the next few years, earnings are expected to grow by 65% per annum.
Industry Valuation and Performance
Has the Taiwanese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 May 2026 | NT$63.7b | NT$42.0b | NT$2.7b | 17.5x | 24x | 1.5x |
| Sat, 18 Apr 2026 | NT$68.7b | NT$41.6b | NT$2.7b | 17x | 25.6x | 1.7x |
| Mon, 16 Mar 2026 | NT$69.3b | NT$42.0b | NT$2.8b | 17.4x | 24.5x | 1.7x |
| Wed, 11 Feb 2026 | NT$71.2b | NT$41.6b | NT$2.9b | 17.2x | 24.9x | 1.7x |
| Fri, 09 Jan 2026 | NT$74.6b | NT$41.6b | NT$2.9b | 17.4x | 26.1x | 1.8x |
| Sun, 07 Dec 2025 | NT$75.7b | NT$41.6b | NT$2.9b | 17.6x | 26.5x | 1.8x |
| Tue, 04 Nov 2025 | NT$73.7b | NT$41.7b | NT$2.8b | 19x | 26.3x | 1.8x |
| Thu, 02 Oct 2025 | NT$74.9b | NT$41.7b | NT$2.8b | 20.1x | 26.7x | 1.8x |
| Sat, 30 Aug 2025 | NT$75.6b | NT$41.7b | NT$2.8b | 18.7x | 27x | 1.8x |
| Mon, 28 Jul 2025 | NT$76.3b | NT$41.3b | NT$3.1b | 17.8x | 24.7x | 1.8x |
| Wed, 25 Jun 2025 | NT$74.7b | NT$41.3b | NT$3.1b | 18.9x | 24.2x | 1.8x |
| Fri, 23 May 2025 | NT$75.8b | NT$41.3b | NT$3.1b | 18.2x | 24.6x | 1.8x |
| Sun, 20 Apr 2025 | NT$78.2b | NT$41.2b | NT$2.7b | 17.9x | 29.3x | 1.9x |
| Tue, 18 Mar 2025 | NT$86.9b | NT$41.0b | NT$2.6b | 19x | 33.7x | 2.1x |
| Thu, 13 Feb 2025 | NT$87.7b | NT$41.2b | NT$2.7b | 20.6x | 32.5x | 2.1x |
| Sat, 11 Jan 2025 | NT$85.3b | NT$39.9b | NT$2.9b | 20.3x | 29.8x | 2.1x |
| Mon, 09 Dec 2024 | NT$88.8b | NT$39.9b | NT$2.9b | 19.6x | 31x | 2.2x |
| Wed, 06 Nov 2024 | NT$82.0b | NT$39.4b | NT$2.8b | 22.6x | 29.2x | 2.1x |
| Fri, 04 Oct 2024 | NT$86.8b | NT$39.4b | NT$2.8b | 23.1x | 30.9x | 2.2x |
| Sun, 01 Sep 2024 | NT$85.5b | NT$39.6b | NT$2.8b | 24.3x | 30.3x | 2.2x |
| Tue, 30 Jul 2024 | NT$84.8b | NT$38.9b | NT$2.8b | 21.5x | 30.5x | 2.2x |
| Thu, 27 Jun 2024 | NT$87.3b | NT$38.9b | NT$2.8b | 24.8x | 31.4x | 2.2x |
| Sat, 25 May 2024 | NT$85.4b | NT$39.0b | NT$2.8b | 20.6x | 30.9x | 2.2x |
| Mon, 22 Apr 2024 | NT$84.3b | NT$38.9b | NT$2.8b | 21.1x | 29.8x | 2.2x |
| Wed, 20 Mar 2024 | NT$88.3b | NT$38.8b | NT$3.0b | 22.7x | 29.8x | 2.3x |
| Fri, 16 Feb 2024 | NT$87.4b | NT$37.9b | NT$2.8b | 23.5x | 31.2x | 2.3x |
| Sun, 14 Jan 2024 | NT$87.0b | NT$37.1b | NT$2.8b | 23.3x | 31.5x | 2.3x |
| Tue, 12 Dec 2023 | NT$84.1b | NT$37.1b | NT$2.8b | 24.1x | 30.5x | 2.3x |
| Thu, 09 Nov 2023 | NT$85.2b | NT$36.9b | NT$2.9b | 24.3x | 29.9x | 2.3x |
| Sat, 07 Oct 2023 | NT$90.1b | NT$37.0b | NT$2.9b | 25.4x | 31x | 2.4x |
| Mon, 04 Sep 2023 | NT$90.4b | NT$37.0b | NT$2.9b | 24.4x | 31.1x | 2.4x |
| Wed, 02 Aug 2023 | NT$94.3b | NT$37.4b | NT$2.9b | 23.4x | 32x | 2.5x |
| Fri, 30 Jun 2023 | NT$101.3b | NT$37.3b | NT$3.0b | 25x | 34.3x | 2.7x |
| Sun, 28 May 2023 | NT$91.4b | NT$37.1b | NT$3.1b | 22.2x | 29.5x | 2.5x |
Price to Earnings Ratio
29.5x
Current Industry PE
- Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 24.0x which is lower than its 3-year average PE of 28.9x.
- The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 5.1% per year over the last three years.
- Meanwhile revenues for these companies have grown 4.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Taiwanese Healthcare industry?
| TW Market | -3.49% | |
| Healthcare | -0.78% | |
| Healthcare Services | -0.81% | |
| Healthcare Distributors | 0.023% | |
| Healthcare Services | -1.64% | |
| Healthcare Facilities | -3.91% | |
Industry PE
- Investors are most optimistic about the Healthcare Distributors industry, which is trading close to its 3-year average PE ratio of 27.4x.
- Analysts are expecting annual earnings growth of 65.2%, which is higher than its past year's earnings growth of 14.2% per year.
- Investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 28.5x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Distributors industry, expecting annual earnings growth of 65% over the next 5 years.
- This is better than its past earnings growth rate of 14% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 65% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4104 Excelsior Medical | NT$70.80 | 3.4% +NT$394.6m | -14.2% | PE14.9x | |
| 4164 CHC Healthcare Group | NT$28.60 | 2.5% +NT$136.7m | -32.4% | PE27.4x | |
| 3218 Universal Vision Biotechnology | NT$130.00 | 0.8% +NT$84.7m | -38.1% | PE11.5x | |
| 7881 Eyecare Tech | NT$104.00 | 2.0% +NT$54.0m | n/a | n/a | |
| 6496 Excelsior Biopharma | NT$24.70 | 3.8% +NT$41.9m | -2.0% | PS1.3x |